Nanotechnology Platforms for Cancer Research
Nanomedik, Inc. is a biotechnology company founded in 2010 dedicated to advancing methods of protein engineering for molecular imaging and nanomedicine.
As the scientific understanding of normal and pathological processes continues to evolve, leading to a need to image different molecular targets, it is important to have strategies that can allow development of molecular imaging probes for "new" molecular targets. Generalizable strategies such as engineered antibodies illustrate how molecular imaging probes can be developed relatively quickly as new molecular targets of interest are discovered.
More info- Research
Nanomedik develops nanotechnology diagnostics and therapeutics for cancer and
View more- Distributors
Nanomedik seeks more international distributors to expand its distribution net
View more- Investors
Nanomedik currently produces smart nanoplatforms for imaging and drug delivery
View moreLatest news
-
April 17, 2012The advent of "Do-It-Yourself Biology" means that you can get started! Check out this how- -
October 19, 2011Researchers at Nanomedik have developed Zirconium-89 radiolabeled Nanomedik products and achieved su -
October 14, 2010Nanomedik enters partnership with the Cornell Nanobiotechnology Center.
Testimonials Research FellowAnonymousThe development of new biomolecular vectors is a particularly fertile area, with the discovery of new cancer biomarkers and advances in protein engineering fueling this growth. Nanomedik is leading the way.
View more info - Distributors